.svg){kind=small}
Richmond Pharmacology presents further QT insulin data next month in San Diego!
30
August 2012
Richmond Pharmacologys latest research on the effect of food on the QT interval Presented at the 6th European Congress of Pharmacology 2012
1
June 2012
DIA 3rd Cardiac Safety Workshop Explores the Future of the TQT Study And Issues Surrounding the Conduct and Analysis of TQT Studies in Japan
9
May 2012
Cardiovascular Safety and State-of-the-art Development Issues 2012: Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity
19
March 2012
QT Assessment in Early Clinical Development Can the Predictive Value be Enhanced to be Similar to That of a TQT study?
15
January 2012
.avif)
Latest news
Richmond Pharmacology Appoints Adam Hurd as Operations Director
August 17, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Adam Hurd as Operations Director
Read moreUpcoming Event
ESC Congress 2026
28 - 31 August 2026
Richmond Pharmacology is pleased to attend the ESC Congress 2026 in Munich, Germany, on 28 - 31 August 2026.
View event
